Spruce Street Capital reported a 5.57% stake in Relmada Therapeutics RLMD · 4,086,181 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.57%
Last report: First report
Shares held: 4,086,181 sh
Class: Common Stock, par value $0.001 per share
Stock: Relmada Therapeutics RLMD
Holder: Spruce Street Capital
Event date: 25/12/31
Filed: 26/02/17

First 5%+ report · 5.57% stake

Relmada Therapeutics trades, last 26 weeks

What else happened in Relmada Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Spruce Street Capital's other 5% stake reports

Spruce Street Capital
5% stakeResearch Alliance Corp III
5% stake
Research Alliance Corp III
RACC
6.4% stake
500,000 sh
6.4% stake
Filed 08/13

Spruce Street Capital reported a 5.57% stake in Relmada Therapeutics RLMD · 4,086,181 sh · passive holder | Whalegun